Table 1 Baseline characteristics of the study groups

Age (years)

43.67 ± 12.63

50.27 ± 13.09

0.052

Sex (No)

 Male

10 (33.3%)

13 (43.3%)

0.426

 Female

20 (66.7%)

17 (56.7%)

BMI (kg/m²)

26.02 ± 5.80

25.74 ± 4.42

0.833

Pruritis duration (years)

1.70 ± 1.24

1.92 ± 1.50

0.764

Duration of HD (years)

4.69 ± 4.34

4.12 ± 3.38

0.673

Cause of ESRD (No)

 -Hypertension

14

16

 -DM

7

3

 -APCKD

2

1

 -GN

5

9

 -Others

2

1

Vascular access (No)

 -AV fistula

25 (83.3%)

27 (90%)

0.706

 -Tunneled catheter

5 (16.7%)

3 (10%)

Dialyzer type (No)

 -Low flux

7 (23.3%)

11 (36.7%)

0.260

 -High flux

23 (76.7%)

19 (63.3%)

Comorbidities (No)

 -Hypertension

29

29

 -DM

8

6

 -IHD

11

18

Phosphate binders (No)

 -Calcium Based

17

15

 -Non-calcium Based

3

2

Alfacalcidol use (No)

11

9

Total cholesterol (mg/dl)

184.5 ± 53.25

179.1 ± 27.37

0.564

Serum triglycerides (mg/dl)

122.07 ± 28.89

126.23 ± 39.95

0.941

Hemoglobin (g/dl)

9.98 ± 1.63

9.81 ± 1.63

0.682

Serum albumin (g/dl)

4.17 ± 0.39

3.98 ± 0.79

0.614

SGPT (u/l)

19.27 ± 7.32

18.37 ± 9.54

0.574

Total bilirubin (mg/dl)

0.69 ± 0.20

0.58 ± 0.21

0.064

Serum calcium (mg/dl)

8.31 ± 0.95

8.59 ± 0.77

0.210

Serum phosphorus (mg/dl)

4.65 ± 0.74

4.57 ± 0.53

0.067

Ca X P product

43.12 ± 21.09

38.99 ± 9.22

0.544

Serum PTH (pg/ml)

298.85 ± 120.23

234.73 ± 234.73

0.082

Ferritin (ng/ml)

512.57 ± 269.35

562.27 ± 266.0

0.455

Urea (mg/dl)

148.62 ± 40.20

129.77 ± 36.17

0.061

Creatinine (mg/dl)

11.34 ± 2.54

10.11 ± 3.52

0.125

Kt/V

1.19 ± 0.08

1.17 ± 0.12

0.683